Evidence map›Paper›PMID 41291804›Full record

ArticleCell communication and signaling : CCS2025

Plexin C1 modulates metabolic programming for resolution of severe inflammation.

Andreas Körner, Michael Koeppen, Jasvir Kaur, Julia C Fitzgerald, Sarantos Kostidis, Torsten Kaussen, Christoph Trautwein, Martin Giera, Tamam Bakchoul, Alice Bernard and 1 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andreas KörnerDepartment of Anesthesiology and Intensive Care Medicine, Molecular Intensive Care Medicine, University Hospital Eberhard Karls University, Tübingen, Germany.
Michael KoeppenDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Eberhard Karls University, Tübingen, Germany.
Jasvir KaurDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Eberhard Karls University, Tübingen, Germany.
Julia C FitzgeraldHertie Institute for Clinical Brain Research, University Clinic Tübingen, Tübingen, Germany.
Sarantos KostidisCenter for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
Torsten KaussenDepartment of Pediatric Cardiology and Pediatric Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Christoph TrautweinWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
Martin GieraCenter for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
Tamam BakchoulTransfusion Medicine, Medical Faculty of Tübingen, University Hospital of Tübingen, Tübingen, Germany.
Alice BernardDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Eberhard Karls University, Tübingen, Germany.
Valbona MirakajDepartment of Anesthesiology and Intensive Care Medicine, Molecular Intensive Care Medicine, University Hospital Eberhard Karls University, Tübingen, Germany. valbona.mirakaj@uni-tuebingen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent, unresolved inflammatory processes disrupt the complex homeostatic state and lead to severe disease, ultimately resulting in organ failure, shock, and death. The mediators that monitor and control the programmed mechanisms in tissue homeostasis and repair remain elusive. A recently discovered group of endogenous proteins, termed neuronal guidance proteins (NGPs), has gained attention as important mediators of immunoregulation and tissue homeostasis through their role in the complex interplay between metabolic reprogramming and immunity. In murine peritonitis, the deficiency of the NGP Plexin C1 (PLXC1−/−) led to an increase in neutrophil and Ly6Chi monocyte recruitment to the injury site and a decrease in the phagocytosis rate. This was accompanied by a decrease in the endogenous biosynthesis of specialized proresolving lipid mediators (SPMs) such as Maresin-1 and Protectin DX and finally by a lengthening of the resolution interval. Peritoneal macrophages (MΦs)PLXC1−/− followed specific strategies to adapt their metabolism to catabolic conditions, by reducing fatty acid oxidation and oxidative phosphorylation, increasing aerobic glycolysis and activation of the pentose phosphate pathway, and disrupting the tricarboxylic acid cycle. The decreased MΦsPLXC1−/− citrate levels corresponded with a lipid mediator profile in which PGD2 and PGE2 were greatly decreased in murine PLXC1−/− peritoneal exudates, indicating a lesser effect on lipid mediator class switching and ultimately the formation of SPMs. Analysis of the related signaling networks indicated mTOR and AKT2 phosphorylation pathways are critical determinants of metabolic reprogramming in activated MΦsPLXC1−/−. These findings highlight a novel role for PLXC1 in regulating the crosstalk between immunometabolism and inflammation resolution programs in severe inflammation.

Indexed as

InflammationNerve Tissue ProteinsAnimalsDocosahexaenoic AcidsMacrophages, PeritonealMetabolic ReprogrammingMicePeritonitisSignal TransductionSpecialized Pro-Resolving MediatorsDocosahexaenoic AcidsNerve Tissue ProteinsInflammationLeukocytesLipid mediatorsMacrophage phenotypeMetabolismNeuronal guidance proteinsPlexin C1RegenerationResolution

Identifiers

PMID41291804
PMCPMC12690942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.